Life Sciences and Technology IPO and SPAC Overview Panel

10:00 am PDT

2020 was another active year in the life sciences and technology markets, despite the impacts of COVID-19. Join our panel with Moss Adams Partners Jeremy Kuhlmann and Findley Gillespie and Fenwick Corporate Partner Amanda Rose, as we recap 2020, look ahead to 2021, and discuss considerations for companies contemplating public exits via initial public offerings (IPOs) or special purpose acquisition companies (SPACs).